B

Bionano Genomics
D

BNGO

3.33000
USD
-0.49
(-12.83%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
9,100,357
أصول ذات صلة
C
CRSP
-1.550
(-4.53%)
32.650 USD
E
EDIT
-0.07000
(-5.88%)
1.12000 USD
F
FATE
-0.07990
(-10.38%)
0.69010 USD
M
MCRB
0.01090
(1.60%)
0.69250 USD
N
NTLA
-0.42000
(-5.75%)
6.88500 USD
P
PACB
-0.07500
(-5.93%)
1.19000 USD
PSTG
PSTG
-5.160
(-11.22%)
40.840 USD
R
RGEN
-9.300
(-7.10%)
121.730 USD
T
TDOC
-0.27000
(-3.46%)
7.53000 USD
V
VCEL
-0.920
(-2.07%)
43.470 USD
المزيد
الأخبار المقالات

العنوان: Bionano Genomics Inc

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.